Company profile
ExAdEx-Innov
Reducing the gap between Lab and Clinical Trials with Physiological and Pathological Non-Animal Models
- Industry
- Biotechnology Research
- Employees
- 8
- Headquarters
- Nice, Provence-Alpes-Côte d'Azur
- Founded
- 2022
- LinkedIn followers
- 3,379
- Office locations
- 1
ExAdEx-Innov company summary
ExAdEx-Innov is a company in the Biotechnology Research industry, headquartered in Nice, Provence-Alpes-Côte d'Azur, founded in 2022. On LinkedIn the company has around 8 employees and 3,379 followers. Its listed specialties include adipose tissue, cosmetic testing, research platform, in vitro, ex vivo.
What technology does ExAdEx-Innov use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ExAdEx-Innov
Unique R&D platform of donor-derived real human adipose tissue ex vivo models for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology to develop preclinical models derived from human adipose tissue obtained from patients. These models maintain their native 3D structure, stem cells, functionality, and vascularization over the long term in culture, providing a faithful representation of clinical conditions. They enable the pharmaceutical industry to generate reliable human data in the laboratory, significantly reducing clinical failure rates and allowing for treatments better tailored to target patient profiles. More ethical, faster, and clinically relevant than animal testing, these models de-risk the evaluation of the efficacy and safety of treatments targeting obesity, metabolic diseases, and dermatological conditions. ExAdEx Technology has been develop in French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. ExAdEx-Innov is member of Eurobiomed and Cosmetic Valley clusters and of Les DeepTech community by BpiFrance.
Specialties
Where is ExAdEx-Innov located?
ExAdEx-Innov lists 1 location.
Compare companies similar to ExAdEx-Innov
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ExAdEx-Innov exadex-innov.com | Biotechnology Research | 8 | 2022 | Nice, Provence-Alpes-Côte d'Azur |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ExAdEx-Innov
What does ExAdEx-Innov do?
Unique R&D platform of donor-derived real human adipose tissue ex vivo models for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology to develop preclinical models derived from human adipose tissue obtained from patients. These models maintain their native 3D structure, stem cells, functionality, and vascularization over the long term in culture, providing a faithful representation of clinical conditions. They enable the pharmaceutical industry to generate reliable human data in the laboratory, significantly reducing clinical failure rates and allowing for treatments better tailored to target patient profiles. More ethical, faster, and clinically relevant than animal testing, these models de-risk the evaluation of the efficacy and safety of treatments targeting obesity, metabolic diseases, and dermatological conditions. ExAdEx Technology has been develop in French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. ExAdEx-Innov is member of Eurobiomed and Cosmetic Valley clusters and of Les DeepTech community by BpiFrance.
How many employees does ExAdEx-Innov have?
ExAdEx-Innov has around 8 employees on LinkedIn.
Where is ExAdEx-Innov headquartered?
ExAdEx-Innov is headquartered in Nice, Provence-Alpes-Côte d'Azur.
When was ExAdEx-Innov founded?
ExAdEx-Innov was founded in 2022.
Build a lead list from companies like ExAdEx-Innov
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.